Pharmaceutical Mergers on the Rise: Why Pfizer (PFE) Could Be a Smart Play
The pharmaceutical industry is seeing a wave of mergers and acquisitions (M&A) aimed at boosting growth amid rising challenges. With an industry-wide shift toward consolidation, companies are navigating expiring patents, heightened R&D costs, and pricing pressures. M&A allows companies to scale, optimize pipelines, and diversify revenue sources, and this environment has piqued interest among investors […]
Source link
